N. Normanno et al., EXPRESSION OF AMPHIREGULIN, CRIPTO-1, AND HEREGULIN-ALPHA IN HUMAN BREAST-CANCER CELLS, International journal of oncology, 2(6), 1993, pp. 903-911
Cripto-1 (CR-1), amphiregulin (AR), and heregulin alpha (HRGalpha) are
three recently discovered epidermal growth factor (EGF)-related pepti
des. The expression of these proteins was determined in MCF-7, ZR-75-1
, T-47D, SK-BR-3, MDA-MB-231, MDA-MB-468, and Hs-578T human breast can
cer cell lines using reverse transcriptase-polymerase chain reaction (
RT-PCR), Northern blotting, and immunocytochemistry (ICC). The express
ion of CR-1 mRNA was detected by RT-PCR in all of the breast cancer ce
ll lines. AR mRNA was detected by Northern blot analysis in MCF-7, ZR-
75-1, T-47D, MDA-MB-231, and MDA-MB-468 cells while HRGalpha mRNA was
expressed in only MDA-MB-231 and Hs-578T cells. All estrogen receptor-
positive cell lines were found to express AR mRNA, and estrogen was ab
le to induce AR mRNA expression in estrogen-depleted MCF-7 cells. CR-1
and AR proteins could be immunocytochemically detected in the breast
cancer cell lines that were expressing CR-1 and AR mRNA using monospec
ific rabbit polyclonal antibodies. The anti-CR-1 antibody was also use
d to examine 26 human primary breast carcinomas by ICC for CR-1 expres
sion. Seventy-five percent of the carcinomas were found to express the
CR-1 protein while the adjacent non-involved breast epithelium was ne
gative. These data demonstrate that CR-1, AR, and HRGalpha are coexpre
ssed in human breast cancer cells and suggest that these three EGF-rel
ated peptides might perform a role in the autocrine growth regulation
of human breast carcinoma cells.